Latest Observability News

Blackstone Minerals has completed its acquisition of IDM International, gaining full control of the Mankayan copper-gold project in the Philippines. The scheme of arrangement is now effective, marking a significant expansion of Blackstone’s Southeast Asia portfolio.

Yowie Group Ltd has formally applied to the Takeovers Panel for a review of its recent decision involving Keybridge Capital Limited, signaling ongoing regulatory scrutiny in this corporate governance matter.

Lithium Energy Limited has completed a 38km passive seismic survey at its White Plains Lithium Brine Project in Utah, revealing a promising Half Graben Basin structure up to 600 metres deep. This milestone sets the stage for advanced geophysical surveys and targeted drilling to define lithium resources.

Turaco Gold has raised A$60 million through a strongly supported placement, positioning the company to fast-track growth and exploration at its flagship Afema gold project.

Lakes Blue Energy NL has secured $6.5 million through a fully underwritten placement to fund drilling at its Wombat Gas Field in Victoria, aiming to address looming gas supply shortages on Australia's east coast.

Patronus Resources has discovered a new high-grade gold shoot at its Merlin Prospect within the Mertondale East Shear Zone, reinforcing the growth trajectory of its Cardinia Gold Project in Western Australia.

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Black Canyon Limited has initiated a 3,000-metre reverse circulation drilling program at its Wandanya Project, aiming to expand on promising high-grade manganese and iron mineralisation along 1.5km of a 3km strike. The program is supported by a WA Government co-funded grant, with assay results expected in the coming months.

Amplia Therapeutics has reported a rare pathological complete response in a patient from its ACCENT trial, highlighting promising potential for its drug narmafotinib in treating advanced pancreatic cancer.

Activeport Group has secured a pivotal contract to deploy its software-defined networking technology for Telekom Malaysia, enabling a shift to automated, self-service fixed-line services across Southeast Asia.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Octava Minerals reports encouraging early-stage bioleaching results from CSIRO on its Byro REE and lithium project, signaling potential for cost-effective and environmentally friendly metal extraction.